SOMNIGROUP INTERNATIONAL INC.

# Signal Note: Driehaus Capital Initiates $41.1M Position in Somni Group International Driehaus Capital's significant entry into SGI (460k shares, $41.1M) signals conviction in the company's sleep disorder pipeline, likely centered on its lead candidate for insomnia and other sleep-related conditions. Given Driehaus's growth-focused biotech mandate, this suggests positive read-through on upcoming clinical data, regulatory milestones, or commercial partnerships expected in near-term windows. The position size ($41.1M for a growth specialist) indicates either undervaluation relative to pipeline risk-reward or anticipated catalyst catalysts within 6-12 months.